These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Studies on the mechanisms of hypersensitivity phenomena. XVI. In vitro assays of reaginic activity in human sera: effect of therapeutic immunization on seasonal titer changes. Levy DA; Osler AG J Immunol; 1967 Dec; 99(6):1068-77. PubMed ID: 4168658 [No Abstract] [Full Text] [Related]
45. Chlorphenesin: a new inhibitor of IgE-mediated histamine release. Lichtenstein LM; Adkinson NF J Immunol; 1969 Oct; 103(4):806-8. PubMed ID: 4186918 [No Abstract] [Full Text] [Related]
46. [Inhibition of anti-IgE-stimulated histamine liberation from sensitized leukocytes of patients with allergic bronchial asthma treated with theophylline]. Morr H; Heinlein P Prax Klin Pneumol; 1984 Apr; 38(4):129-31. PubMed ID: 6201838 [No Abstract] [Full Text] [Related]
49. The effect of in vitro exposure to histamine on mononuclear leucocyte phosphodiesterase activity in atopic dermatitis. Holden CA; Yuen CT; Coulson IH Clin Exp Dermatol; 1989 May; 14(3):186-90. PubMed ID: 2556225 [TBL] [Abstract][Full Text] [Related]
50. Impairment of the β-Adrenergic System of Peripheral Blood Leukocytes in Atopic Patients with Seasonal Allergic Rhinoconjunctivitis. Haen E; Bleise U; Przybilla B Int Arch Allergy Immunol; 1992; 99(2-4):435-438. PubMed ID: 34167258 [TBL] [Abstract][Full Text] [Related]
51. Inhibition of IgE-mediated histamine release from human peripheral leukocytes by selective phosphodiesterase inhibitors. Kleine-Tebbe J; Wicht L; Gagné H; Friese A; Schunack W; Schudt C; Kunkel G Agents Actions; 1992 Jul; 36(3-4):200-6. PubMed ID: 1382373 [TBL] [Abstract][Full Text] [Related]
52. Some alterations of the leucocyte beta2-adrenoceptor/cAMP-system in patients with seasonal allergic rhinoconjunctivitis are related to disease activity. Haen E; Bleise U; Przybilla B Clin Exp Allergy; 1997 Jul; 27(7):787-95. PubMed ID: 9249271 [TBL] [Abstract][Full Text] [Related]
53. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy. Rak S; Heinrich C; Scheynius A Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810 [TBL] [Abstract][Full Text] [Related]
54. Selective type IV phosphodiesterase inhibitors prevent IL-4-induced IgE production by human peripheral blood mononuclear cells. Coqueret O; Boichot E; Lagente V Clin Exp Allergy; 1997 Jul; 27(7):816-23. PubMed ID: 9249275 [TBL] [Abstract][Full Text] [Related]
55. [Inhibition of histamine liberation in allergic rhinoconjunctivitis in relation to the season]. Räderer I; Haen E; Schudt C; Przybilla B Wien Med Wochenschr; 1995; 145(17-18):456-8. PubMed ID: 8588365 [TBL] [Abstract][Full Text] [Related]